United States: Respiratory illnesses are again making their way to the United States. The fear has re-emerged because the cases linked to Parvovirus B19 – which is a seasonal virus – have been increasing, according to the health officials.
The warning related to the comeback of the virus was issued by health officials on Tuesday by the US Centers for Disease Control and Prevention. According to the latest reports by the federal health agency, the test positivity rates linked to the infection have increased in recent months.
Accordingly, the proportion of people having recent infection fell below 3 percent between 2022 and 2024, but it suddenly raised and reached to 10 percent in June. The reports have further revealed that the children between ages of five and nine have hit the most in the recent wave. The infection rate for this age group has went up to 40 percent in June 2024 from just 15 percent in 2022-2024.
Is the spread Only Seen in the US?
According to the recent update, the United States is not the only country that has experienced an upsurge in cases linked to parvovirus. In June 2024, the European Centers for Disease Control and Prevention reported that an upsurge in the cases had been reported in at least 14 countries during the first quarter of the year 2024.
How to Explain Parvovirus?
As per the health experts, parvovirus is also known as “slapped cheek disease,” which results in the facial rash. Mostly, children are infected from the infection. The official data has revealed that around 50 percent of the Americans have detachable levels of parvovirus B19 virus antibodies by the age of 20 and more than 70 percent have antibodies at the age of 70.
Along with the children, the people who are in close contact with children, especially those who work at schools and daycare centers, also have a higher risk of infection, according to the health experts at the CDC.
The health authorities have also outlined that, unlike other respiratory illnesses, to avoid the spread of this illness, social distancing is important and plays a crucial role in dramatically lowering the parvovirus B19 infection rates.
The concerns of the health authorities are high because the CDC has outlined that it has reported higher-than-expected case counts among pregnant people, which could lead to complications such as severe fetal anemia or miscarriage.
What are the Commonly Seen Symptoms?
It is to be noted that during the initial stage, many people don’t witness any symptoms but there are typically two phases of illness, as per CDC. During the first phase of the illness, the infected person can develop fever, muscle aches and malaise – lasting for about five days.
During the second phase, the infected individual starts experiencing a facial rash, accompanied by a body rash or joint pain. If the disease enters the second phase, this is when people become most contagious.
Besides this, some individuals deal with complications if they catch the infection, such as people with sickle cell disease or those who have weakened immune systems may develop aplastic anemia – a rare and dangerous blood disorder.
It is also reconsidered as a concern among pregnant people as about 5 percent to 10 percent of people can develop anemia or a condition of miscarriage.
Vaccine against the infection!
The health experts have suggested that as of now, there is no vaccination for parvovirus and the infection cannot be treated. But, the CDC has outlined that the infection could be resolved on its own if special care provided.
With increase in the cases, the health agency has asked to the general public to follow some basic health precautions.